POLYMED.BOPOLYMED.BOBSE
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+8.6%
5Y CAGR+31.3%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+8.6%/yr
vs +21.8%/yr prior
5Y CAGR
+31.3%/yr
Recent deceleration
Acceleration
-13.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.9x
Strong expansion
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
202512.81+15.3%
202411.11+33.4%
20238.33-16.7%
202210.00+5.3%
20219.49+188.7%
20203.29-2.4%
20193.37-26.0%
20184.55-15.6%
20175.39+71.6%
20163.14-